Medicare Enrolled

Dr. Yanina Kotlyar, MD

Internal Medicine · New City, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
20 SQUADRON BLVD, New City, NY 10956
8456348800
In practice since 2006 (20 years)
NPI: 1396717153 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kotlyar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kotlyar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kotlyar

Dr. Yanina Kotlyar is an internal medicine specialist in New City, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kotlyar performed 6,609 Medicare services across 3,091 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kotlyar received a total of $2,019 from 16 pharmaceutical and/or device companies across 98 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kotlyar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 4% volume in NY $2,019 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,609
Medicare services
Top 4% in NY for internal medicine
3,091
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~330 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
1,360 $4 $14
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
798 $111 $206
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
715 $77 $141
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
713 $8 $30
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
686 $3 $38
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
330 $13 $34
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
227 $62 $96
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
184 $149 $224
Autonomic nervous system testing with heart rate response to deep breathing
This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing.
168 $79 $172
Autonomic nervous system function test
This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure.
168 $103 $514
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
152 $24 $74
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
115 $35 $126
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
115 $41 $93
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
115 $54 $123
Exercise stress test
A test that monitors the heart and lungs while the patient exercises to evaluate their function under physical stress.
114 $134 $321
Lung volume measurement test
A test that measures the largest amount of air you can breathe in and out. It evaluates the total capacity of your lungs.
113 $15 $52
Breathing device use evaluation
An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling.
113 $17 $38
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
104 $48 $85
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
95 $156 $966
Ultrasound of arm and leg arteries
A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues.
81 $99 $286
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
65 $13 $50
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
58 $1 $7
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
20 $137 $319
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
4.8% medium
93.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,019
Total received (2018-2024)
Avg $288/year across 7 years
Top 27% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
16
Companies
98
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,675 (83.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$344 (17.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$204
2023
$488
2022
$446
2021
$144
2020
$436
2019
$200
2018
$100

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$60
Lilly USA, LLC
$40
ABBVIE INC.
$34
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$21
AIMMUNE THERAPEUTICS, INC.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
AstraZeneca Pharmaceuticals LP
$15
Top 3 companies account for 65.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$374
Astellas Pharma US Inc
$365
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$333
Boehringer Ingelheim Pharmaceuticals, Inc.
$195
AstraZeneca Pharmaceuticals LP
$181
Lilly USA, LLC
$179
Janssen Pharmaceuticals, Inc
$118
ABBVIE INC.
$65
Allergan, Inc.
$40
Abbott Laboratories
$39
Novartis Pharmaceuticals Corporation
$36
PFIZER INC.
$25
Amarin Pharma Inc.
$24
AIMMUNE THERAPEUTICS, INC.
$18
MEDLINE INDUSTRIES LP
$14
Almatica Pharma LLC
$14
Top 3 companies account for 53.1% of all-time payments
Associated products mentioned in payments ›
BASAGLAR · EMGALITY · ENTRESTO · FARXIGA · FREESTYLE LIBRE · INVOKANA · JARDIANCE · LINZESS · LOREEV XR · LYRICA · MOUNJARO · MYRBETRIQ · Ozempic · RYBELSUS · Rybelsus · SPRAVATO · TRULANCE · UBRELVY · VESICARE · Vascepa · Wegovy · XARELTO · XIFAXAN · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (83%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an internal medicine specialist in New City?
Compare internal medicine physicians in the New City area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
3,710
Per 100K population
1094.6
County median income
$110,631
Nearest hospital
HELEN HAYES HOSPITAL
4.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kotlyar is a clinical cardiology specialist, with above-average Medicare volume (top 4% in NY), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kotlyar experienced with allergy skin test?
Based on Medicare claims data, Dr. Kotlyar performed 1,360 allergy skin test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kotlyar receive payments from pharmaceutical companies?
Yes. Dr. Kotlyar received a total of $2,019 from 16 companies across 98 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kotlyar's costs compare to other internal medicine physicians in New City?
Dr. Kotlyar's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kotlyar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →